| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/28/2004 | CN1471527A 喹唑啉衍生物 Quinazoline derivatives |
| 01/28/2004 | CN1471523A Imidazole derivatives as Raf kinase inhibitors |
| 01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471515A Compounds effective as beta-2-adrenoreceptor agonists as well as PDE-4-inhibitors |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1471404A Antiparkinsonism drugs |
| 01/28/2004 | CN1471397A Method for treatment of migraine |
| 01/28/2004 | CN1471395A Apomorphine derivatives and methods for their use |
| 01/28/2004 | CN1471394A Tripeptidyl peptidase inhibitors |
| 01/28/2004 | CN1471393A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1471392A Method for the treatment of neurological and neuropsychological disorders |
| 01/28/2004 | CN1470528A Snake venom enzyme nerve growth factor for treating diabetic concurrent peripheral nervous pathological complication |
| 01/28/2004 | CN1470279A Detoxifying and smoking-stopping cigarette, and its preparing method and use |
| 01/28/2004 | CN1470278A Detoxifying and smoking-stopping tea and its preparing method |
| 01/28/2004 | CN1470266A Chinese medicinal powder for treating Bell's palsy |
| 01/28/2004 | CN1470249A Yak-blood deproteined extract and its extraction method and use thereof |
| 01/28/2004 | CN1136214C Heteroaromatic derivatives |
| 01/28/2004 | CN1136212C Thiophene nitrone compounds |
| 01/28/2004 | CN1136203C Benzoxazine and penzothiazine derivatives and their use in pharmaceuticals |
| 01/28/2004 | CN1136201C Pharmacologucally active enantiomers and method for their preparation |
| 01/28/2004 | CN1136200C Pharmacollogically active enantiomers and method for their preparation |
| 01/28/2004 | CN1136197C Novel pyridajinone derivatives |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/28/2004 | CN1135991C Oral liquid for preventing and curing senile dementia and its preparing process |
| 01/28/2004 | CN1135982C Process for preparing pharmaceutical composition containing N-acyl-2,3-benzodiazepine deriratives |
| 01/28/2004 | CN1135981C Morphine sulphate microgranules, and method for making same and pharmaceutical preparations |
| 01/27/2004 | US6683192 Substituted benzo(b)thien compounds useful for modulating proliferation or differentiation of a cell, agonizes hedgehog mediated signal trasnduction with an ed50 of 1mm or less |
| 01/27/2004 | US6683111 Such as 2-ethoxy-3-(4-(2-xanthen-9-ylidene-ethoxy)-phenyl)-propionic acid; for treating conditions associated with peroxisome proliferator-activated receptors; treatment of diabetes/obesity |
| 01/27/2004 | US6683105 Highly selective butyrylcholinesterase inhibitors such as cymserine or others can prevent or treat cognitive impairments associated with aging or alzheimer's disease |
| 01/27/2004 | US6683101 Such as 6-(3-(trans-4-phenylcyclohexylamino)propyl)-3h-benzoxazol-2-one; cerebral vascular disorders |
| 01/27/2004 | US6683097 Imidazole derivatives |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683091 Heterocyclic sulfanamides; alzheimer's disease; preventing deposition of amyloid protein |
| 01/27/2004 | US6683090 N-(1-azabicyclo(2.2.2)oct-3-yl)propenamide derivatives; psychotic and intellectual impairment disorders |
| 01/27/2004 | US6683089 N-allyoxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-ols |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683087 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 01/27/2004 | US6683086 Ultrashort acting hypnotic barbiturates |
| 01/27/2004 | US6683081 Triazolotriazinones and the use thereof |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683076 Methods for therapeutic use of glucosylceramide synthesis inhibitors and composition thereof |
| 01/27/2004 | US6683056 Synergistic mixture with antilipemic agent |
| 01/27/2004 | US6683055 Guanidine or amidine termined peptides |
| 01/27/2004 | US6683053 Insulin-like growth factor agonist molecules |
| 01/27/2004 | US6683049 Relieving pain from neuromuscular disorders using botulinum toxins |
| 01/27/2004 | US6682757 Patch units |
| 01/27/2004 | CA2292920C New spiroimidazolin derivatives, the process for preparing them and the pharmaceutical compositions that contain them |
| 01/27/2004 | CA2256247C New naphtalene compounds, their preparation and pharmaceutical compositions containing them |
| 01/27/2004 | CA2254772C Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/27/2004 | CA2129043C Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and oedema |
| 01/27/2004 | CA2120048C Pharmaceutical composition having analgesic activity |
| 01/27/2004 | CA2098821C Benzodioxane derivatives |
| 01/27/2004 | CA2081604C Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| 01/27/2004 | CA2050569C Diphenyl compounds which inhibit arachidonic acid metabolism, and their use in pharmaceutical compositions |
| 01/22/2004 | WO2004008101A2 The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates |
| 01/22/2004 | WO2004007700A1 Process for producing nerve cells |
| 01/22/2004 | WO2004007696A2 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 01/22/2004 | WO2004007655A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid |
| 01/22/2004 | WO2004007654A1 A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 01/22/2004 | WO2004007517A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 01/22/2004 | WO2004007515A1 Sulfotransferase inhibitors |
| 01/22/2004 | WO2004007503A1 Therapeutic or preventive agent for nausea/vomiting |
| 01/22/2004 | WO2004007496A1 Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides |
| 01/22/2004 | WO2004007495A1 Pyrrolopyridine derivative and use thereof |
| 01/22/2004 | WO2004007494A1 Phenylalanine enamide derivatives |
| 01/22/2004 | WO2004007491A1 Azolidinone-vinyl fused-benzene derivatives |
| 01/22/2004 | WO2004007487A1 Crystalline forms |
| 01/22/2004 | WO2004007486A1 Maleate salts |
| 01/22/2004 | WO2004007485A1 Besylate salts |
| 01/22/2004 | WO2004007484A1 Fumarate salts |
| 01/22/2004 | WO2004007478A2 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 01/22/2004 | WO2004007472A1 Ccr4 antagonist and medicinal use thereof |
| 01/22/2004 | WO2004007468A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/22/2004 | WO2004007464A1 Imidazole derivative |
| 01/22/2004 | WO2004007461A1 8-hydroxy quinoline derivatives |
| 01/22/2004 | WO2004007457A2 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | WO2004007454A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 01/22/2004 | WO2004007453A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 01/22/2004 | WO2004007442A1 Prostaglandin derivatives |
| 01/22/2004 | WO2004007437A1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 01/22/2004 | WO2004007430A2 Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands |
| 01/22/2004 | WO2004007429A1 Cinnamide derivatives |
| 01/22/2004 | WO2004007423A1 Novel salt forms of poorly soluble probucol esters and ethers |
| 01/22/2004 | WO2004007417A1 Enzyme inhibitors |
| 01/22/2004 | WO2004006958A1 Stable pharmaceutical composition comprising erythropoietin |
| 01/22/2004 | WO2004006956A1 Drugs for improving the prognosis of brain injury and a method of screening the same |
| 01/22/2004 | WO2004006954A2 Transdermal botulinum toxin compositions |
| 01/22/2004 | WO2004006946A1 Composition comprising the crude extract of the fruit of morus alba l having neuro-protective activity |
| 01/22/2004 | WO2004006944A1 Flower essence-containing medicaments |
| 01/22/2004 | WO2004006940A1 Medicinal composition for drug-induced neuropathy |
| 01/22/2004 | WO2004006935A1 Use of compounds that activate the sterol regulatory element binding protein (srebp) pathway |
| 01/22/2004 | WO2004006933A2 Crystal forms of olanzapine and processes for their preparation |
| 01/22/2004 | WO2004006930A1 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 01/22/2004 | WO2004006929A1 Composition for nasal absorption |
| 01/22/2004 | WO2004006919A1 Medicinal composition for mitigating blood lipid or lowering blood homocystein |
| 01/22/2004 | WO2004006918A1 Phenylalanine enamide derivatives containing a spiro`3.5!non-1-ene ring for use as integrin inhibitors |
| 01/22/2004 | WO2004006915A1 Angiotensin non-at1 receptor stimulating agents for brain ischemia protection and for acute stroke treatment |
| 01/22/2004 | WO2004006911A2 Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same |
| 01/22/2004 | WO2004006905A1 Modafinil pharmaceutical compositions |